In Vitro Fertilization Device Market Scope
Vitro fertilization (IVF) encompasses a multifaceted sequence of techniques employed to address fertility challenges, mitigate genetic disorders, and facilitate the successful conception of a child. Supportive regulations and policies concerning infertility treatment and assisted reproductive technologies have been implemented in numerous countries, enhancing the accessibility and adoption of IVF devices. This, in turn, contributes significantly to the growth of the market. The progress in medical science and technology has resulted in the refinement of techniques and procedures utilized in IVF, leading to improved success rates. Changes in societal and lifestyle patterns, including the trend of delayed parenthood driven by factors like career progression, financial stability, and personal preferences, have resulted in an increased demand for fertility treatments such as IVF.
|Unit||Value (USD Million)|
|Key Companies Profiled||Fujifilm Irvine Scientific. (United States), Esco Micro Pte. Ltd. (Singapore), Ferti·Lily (United Kingdom), Vitrolife (Germany), Cook (United States), CooperSurgical, Inc. (United States), Merck KGaA (Germany), A CooperSurgical Fertility Company (United States), Kitazato Corporation (Japan) and Virtual Expo Group (Italy)|
Sustaining a competitive advantage in the IVF device market necessitates continuous innovation, a deep understanding of customer requirements, and staying abreast of advancements in reproductive technology. By consistently introducing new and improved solutions, addressing evolving customer needs, and incorporating the latest scientific and technological developments, companies can position themselves ahead of the competition. This proactive approach enables them to offer cutting-edge devices that deliver superior performance, improved outcomes, and a positive user experience. Additionally, maintaining strong relationships with healthcare professionals, patients, and key stakeholders in the industry facilitates a better understanding of market dynamics and ensures that products meet the highest standards of quality, safety, and efficacy. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global In Vitro Fertilization Device market throughout the predicted period.
Fujifilm Irvine Scientific. (United States), Esco Micro Pte. Ltd. (Singapore), Ferti·Lily (United Kingdom), Vitrolife (Germany), Cook (United States), CooperSurgical, Inc. (United States), Merck KGaA (Germany), A CooperSurgical Fertility Company (United States), Kitazato Corporation (Japan) and Virtual Expo Group (Italy) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Hamilton Thorne, Inc. (United States), Sefi Medical (Israel), WillCo Wells B.V. (Netherlands), Baymed Inovative Health Products Inc. (United States) and Nerbe Plus GmbH (Germany).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global In Vitro Fertilization Device market by Type , by Application (Surgical Centers, Clinical Research Institutes, Fertility Clinics, Hospitals and Others) and Region with country level break-up.
On the basis of geography, the market of In Vitro Fertilization Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.
Market Leaders and their expansionary development strategiesIn March 2022, Fujifilm Corporation acquired Shenandoah Biotechnology, Inc., a reputable manufacturer known for its expertise in producing recombinant proteins. This strategic acquisition will further strengthen the capabilities and offerings of the acquiring company in the field of recombinant protein manufacturing. and In Feb 2022, CooperCompanies acquired Cook Medical's Reproductive Health business. This business division is known for its expertise in manufacturing minimally invasive medical devices that cater to the fertility, obstetrics, and gynecology markets. This collaboration ensures a smooth transition while providing CooperSurgical with the necessary resources to meet the increasing demand for its products
In May 2022, FERTI·LILY introduced the FERTI·LILY Conception Cup, a reusable medical device that enhances couples' chances of conception by 48%, providing them with an opportunity to boost their fertility. FERTI·LILY strives to empower couples by offering them greater control over their fertility journey. Their objective is to enhance the chances of conception while preserving the intimate and exciting nature of this significant milestone in their lives. and In June 2022, FUJIFILM Irvine Scientific, Inc., obtained an exclusive license for intellectual property related to artificial intelligence (AI) for image-based assessment of human embryos. This development aims to enhance the success rates of in-vitro fertilization (IVF) by leveraging AI technology.
Influencing Trend:Innovations in Time-lapse imaging to monitor the embryo development in real time and Rise in the inclination toward elective egg freezing
Market Growth Drivers:Rising prevalence of infertility and high success rate of IVF & ICSI and Advancements in technology like laser-assisted hatching
Challenges:IVF treatments can be expensive because of the advanced technology & less risk and Maintaining quality control for these types of treatments is challenging
Restraints:IVF treatments can be emotionally and psychologically demanding for individuals and couples and Maintaining consistent quality control and standardization across IVF devices
Opportunities:Continuous demand for highly accurate and efficient devices that enhance procedure success rates and Implementing automation and robotics technologies
Key Target AudienceManufacturers/Suppliers, Healthcare Institutions, Customers, End Users, Market Research Organizations, Potential Investors and Others